Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00058058 · ClinicalTrials.gov registry record · NA
Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer
A NA study of Breast Cancer and Contralateral Breast Cancer, sponsored by American College of Radiology Imaging Network.
- Completed
- Registry status
- NA
- Development phase
- 1,007
- Enrollment target
- 20
- Study locations
NCT00058058: Completed NA study of Breast Cancer and Contralateral Breast Cancer, sponsored by American College of Radiology Imaging Network.
NCT00058058 is a NA study of Breast Cancer and Contralateral Breast Cancer that has completed, run by American College of Radiology Imaging Network. The registered enrollment target is 1,007 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (64% lower). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00058058, a NA study of Breast Cancer and Contralateral Breast Cancer, has completed, sponsored by American College of Radiology Imaging Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,007 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may improve the ability to detect cancer in the unaffected breast of women recently diagnosed with unilateral breast cancer. PURPOSE: Diagnostic trial to determine the effectiveness of MRI in evaluating the unaffected breast of women recently diagnosed with unilateral breast cancer.
Primary Outcome
To assess the diagnostic yield of magnetic resonance imaging (MRI) in evaluating the contralateral breast of women with a recent unilateral diagnosis of breast cancer and a negative contralateral mammogram and clinical breast exam. the "Test" status was defined based on combinations of the following 4 factors: 1. The initial BI-RADs: from the MRI of the contralateral breast 2. The final BI-RADs: determined after all subsequent work-up and follow-up within 365 from the initial MRI (an explicit
Conditions Studied
Interventions
- PROCEDURE MRI
Study Locations (20)
Pennsylvania
- Abramson Cancer Center at University of Pennsylvania Medical Center - Philadelphia
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia - Philadelphia
- Allegheny General Hospital - Pittsburgh
California
- Jonsson Comprehensive Cancer Center, UCLA - Los Angeles
- UCSF Comprehensive Cancer Center - San Francisco
Florida
- Boca Raton Community Hospital - Boca Raton
- Mayo Clinic - Jacksonville
Illinois
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University - Chicago
- Memorial Medical Center - Springfield
Arkansas
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences - Little Rock
Colorado
- Porter Adventist Hospital - Denver
Connecticut
- Hartford Hospital - Hartford
District of Columbia
- Walter Reed Army Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,007 participants |
| Start Date | 2003-02 |
| Est. Completion | 2008-08 |
| Phase | NA |
What the finished NCT00058058 record still lists
NCT00058058 is an interventional study that assigns participants to a tested intervention. Its 1,007 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which MRI is the first listed.
NCT00058058 names 20 study sites across 15 states, led by Pennsylvania, California, Florida.
Frequently Asked Questions
What is clinical trial NCT00058058 about?
NCT00058058 is a clinical study titled "Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer". RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may improve the ability to detect cancer in the unaffected breast of women recently diagnosed with unilateral breast cancer. PURPOSE: Diagnostic trial to determine the effectiveness of MRI in evaluating the unaffected breast ...
What is the current status of trial NCT00058058?
This trial is currently completed. It is a NA study. The enrollment target is 1,007 participants. The study started on 2003-02. Estimated completion is 2008-08.
What conditions does trial NCT00058058 study?
This clinical trial studies the following conditions: Breast Cancer, Contralateral Breast Cancer.
What interventions are being tested in trial NCT00058058?
The interventions under investigation include: MRI (PROCEDURE).
Who is sponsoring clinical trial NCT00058058?
This trial is sponsored by American College of Radiology Imaging Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00058058 being conducted?
This trial has 20 study locations across Arkansas, California, Colorado, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00058058's enrollment target sits among peer trials
1,007 119th of 1224 higher than 1,106 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT04389632 · 1,006 participants · Phase 1
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- NCT06207864 · 1,001 participants · NA
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia